METHODS FOR INFERENCE ON TRANSMISSION IN SEROPREVALENCE DATA FOR MULTIPLE INFECTIONS

被引:6
作者
EVANS, AA
LEFKOPOULOU, M
MUELLER, NE
机构
[1] HARVARD UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV BIOSTAT & EPIDEMIOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH PUBL HLTH, DEPT BIOSTAT, BOSTON, MA 02115 USA
关键词
CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC METHODS; HEPATITIS-B VIRUS; HEPATITIS-C VIRUS; MODELS; STATISTICAL; PREVALENCE; SEROLOGY;
D O I
10.1093/oxfordjournals.aje.a116216
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
When risk factors for an infectious disease are unknown, a method commonly employed is to investigate parallels with known infections (covariate infections). Data sets of value here are those for specified populations in which the seroprevalence of antibodies for multiple infections has been ascertained, The use of markers of covariate infections in multivariable analyses is problematic when the covariate infection is not itself an independent risk factor for the outcome of interest. In the performance of these analyses, the authors recommend the following strategy: 1) For estimates of the effects of measured risk factors on the outcome, adjustment for the covariate infection should not be done; this will avoid problems of overadjustment. 2) After control for the measured risk factors, an estimate of the "effect" of the covariate infection may be used as an indicator of the presence of unmeasured shared risk factors. 3) When shared, measured risk factors exist, the authors propose the use of methods developed for analysis of repeated measures of categorical variables to assist in inference about shared mechanisms of action of these risk factors. This analytic strategy takes advantage of the method of analogy for building understanding of transmission of new agents through their parallels with better known ones and is useful in the development of hypotheses.
引用
收藏
页码:1156 / 1165
页数:10
相关论文
共 16 条
[1]  
AGRESTI A, 1990, CATEGORICAL DATA ANA, P386
[2]   RISK-FACTORS FOR ACUTE NON-A, NON-B HEPATITIS IN THE UNITED-STATES AND ASSOCIATION WITH HEPATITIS-C VIRUS-INFECTION [J].
ALTER, MJ ;
HADLER, SC ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
MOYER, LA ;
FIELDS, HA ;
BRADLEY, DW ;
MARGOLIS, HS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (17) :2231-2235
[3]  
BLATTNER WA, 1990, J ACQ IMMUN DEF SYND, V3, P1102
[4]   FACTORS ASSOCIATED WITH PREVALENT HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION IN THE MULTICENTER AIDS COHORT STUDY [J].
CHMIEL, JS ;
DETELS, R ;
KASLOW, RA ;
VANRADEN, M ;
KINGSLEY, LA ;
BROOKMEYER, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (04) :568-577
[5]   OVER-ADJUSTMENT IN CASE-CONTROL STUDIES [J].
DAY, NE ;
BYAR, DP ;
GREEN, SB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1980, 112 (05) :696-706
[6]  
EVANS AA, 1991, THESIS HARVARD SCH P
[7]   CONFOUNDING AND MISCLASSIFICATION [J].
GREENLAND, S ;
ROBINS, JM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 122 (03) :495-506
[8]   GENERAL METHODOLOGY FOR ANALYSIS OF EXPERIMENTS WITH REPEATED MEASUREMENT OF CATEGORICAL DATA [J].
KOCH, GG ;
LANDIS, JR ;
FREEMAN, JL ;
FREEMAN, DH ;
LEHNEN, RG .
BIOMETRICS, 1977, 33 (01) :133-158
[9]   AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS [J].
KUO, G ;
CHOO, QL ;
ALTER, HJ ;
GITNICK, GL ;
REDEKER, AG ;
PURCELL, RH ;
MIYAMURA, T ;
DIENSTAG, JL ;
ALTER, MJ ;
STEVENS, CE ;
TEGTMEIER, GE ;
BONINO, F ;
COLOMBO, M ;
LEE, WS ;
KUO, C ;
BERGER, K ;
SHUSTER, JR ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :362-364
[10]   LONGITUDINAL DATA-ANALYSIS USING GENERALIZED LINEAR-MODELS [J].
LIANG, KY ;
ZEGER, SL .
BIOMETRIKA, 1986, 73 (01) :13-22